Duchenne muscular dystrophy is a rare degenerative condition that causes muscle weakness, loss of movement and eventually death.
Santhera’s proposed treatment, Raxone, aims to treat the respiratory failure associated with the disease, according to the report.
More articles on supply chain:
Why pharmacists can’t speak up when they know customers are overpaying for drugs
Sanofi, Lonza to build $285M biologics facility
Pharma leaders, healthcare experts advocate value-based payments for drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
